Who
Alexandre Weinstein Manieu
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, Pluri.
In numbers
- Trades disclosed
- 22
- Buys
- 1
- Sells
- 0
- Bought
- $2.1M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 23 Jan 2025
- Last trade
- 20 Aug 2026
- Last filed
- 24 Aug 2026
Companies traded
Activity over time
1 Apr 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Aug 2026filed 24 Aug 2026 | PLUR PluriBiotechnology | SEC FORM 4 Code A | —180,000 at $0.00 | filing |
| 20 Aug 2026filed 24 Aug 2026 | PLUR PluriBiotechnology | SEC FORM 4 Code A | —180,000 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | PLUR PluriBiotechnology | SEC FORM 4 Code A | —641 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | PLUR Plurioption or derivative · Biotechnology | SEC FORM 4 Code E | —625,000 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | PLUR Plurioption or derivative · Biotechnology | SEC FORM 4 Code E | —625,000 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | PLUR PluriBiotechnology | SEC FORM 4 Code A | —641 at $0.00 | filing |
| 21 Apr 2026filed 4 May 2026 | PLUR PluriBiotechnology | SEC FORM 4 Code A | $625K312,500 at $2.00 | filing |
| 21 Apr 2026filed 4 May 2026 | PLUR Plurioption or derivative · Biotechnology | SEC FORM 4 Code A | $625K312,500 at $2.00 | filing |
| 21 Apr 2026filed 4 May 2026 | PLUR Plurioption or derivative · Biotechnology | SEC FORM 4 Code A | $625K312,500 at $2.00 | filing |
| 21 Apr 2026filed 4 May 2026 | PLUR PluriBiotechnology | SEC FORM 4 Code A | $625K312,500 at $2.00 | filing |
| 31 Mar 2026filed 4 May 2026 | PLUR PluriBiotechnology | SEC FORM 4 Code A | $625K312,500 at $2.00 | filing |
| 31 Mar 2026filed 4 May 2026 | PLUR Plurioption or derivative · Biotechnology | SEC FORM 4 Code A | $625K312,500 at $2.00 | filing |
| 31 Mar 2026filed 4 May 2026 | PLUR Plurioption or derivative · Biotechnology | SEC FORM 4 Code A | $625K312,500 at $2.00 | filing |
| 31 Mar 2026filed 4 May 2026 | PLUR PluriBiotechnology | SEC FORM 4 Code A | $625K312,500 at $2.00 | filing |
| 8 Dec 2025filed 5 Jan 2026 | PLUR PluriBiotechnology | SEC FORM 4 Code A | $1.3M625,000 at $2.00 | filing |
| 8 Dec 2025filed 5 Jan 2026 | PLUR Plurioption or derivative · Biotechnology | SEC FORM 4 Code A | $1.3M625,000 at $2.00 | filing |
| 29 Oct 2025filed 20 Nov 2025 | PLUR Plurioption or derivative · Biotechnology | SEC FORM 4 Code M | —1,002,169 at $0.00 | filing |
| 29 Oct 2025filed 20 Nov 2025 | PLUR PluriBiotechnology | SEC FORM 4 Code M | —1,002,169 at $0.00 | filing |
| 28 Apr 2025filed 20 Nov 2025 | PLUR PluriBiotechnology | SEC FORM 4 Bought | $2.1M452,702 at $4.61 | filing |
| 25 Feb 2025filed 20 Nov 2025 | PLUR PluriBiotechnology | SEC FORM 4 Code A | —10,250 at $0.00 | filing |
News
Pluri Chairman and Active Investor Alejandro Weinstein to Acquire EIB Loan, in Strong Vote of Confidence in the CompanyPLUR · manilatimes.net · 21 Oct 2026Head to Head Comparison: Cytokinetics (NASDAQ:CYTK) vs. Pluri (NASDAQ:PLUR)PLUR · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Alexandre Weinstein Manieu; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.